Literature DB >> 16695214

THE CONVERSION OF HEMATIN TO BILIRUBIN FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMAN SUBJECTS.

I J Pass1, S Schwartz, C J Watson.   

Abstract

Entities:  

Year:  1945        PMID： 16695214      PMCID： PMC435456          DOI： 10.1172/JCI101604

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  7 in total

1.  METHEMALBUMIN. I. APPEARANCE DURING ADMINISTRATION OF PAMAQUINE AND QUININE.

Authors:  M Rosenfeld; C G Zubrod; W D Blake; J A Shannon
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

2.  METHEMALBUMIN. II. EFFECT OF PAMAQUINE AND QUININE ON PATHWAYS OF HEMOGLOBIN METABOLISM.

Authors:  W D Blake
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

3.  Pseudohemoglobin and the Catabolism Of Heme Compounds.

Authors:  C LIEBECQ
Journal:  Experientia       Date:  1948-02-15

4.  Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria.

Authors:  C J Watson; I Bossenmaier; R Cardinal; Z J Petryka
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

5.  Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin.

Authors:  H L Bonkowsky; D P Tschudy; A Collins; J Doherty; I Bossenmaier; R Cardinal; C J Watson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

6.  Carbon monoxide production associated with ineffective erythropoiesis.

Authors:  P White; R F Coburn; W J Williams; M I Goldwein; M L Rother; B C Shafer
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

Review 7.  Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know.

Authors:  Petro E Petrides
Journal:  Diagnostics (Basel)       Date:  2022-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.